These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16279538)

  • 41. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
    Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
    Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen.
    Chiuchiolo MJ; Boyer JL; Krause A; Senina S; Hackett NR; Crystal RG
    J Infect Dis; 2006 Nov; 194(9):1249-57. PubMed ID: 17041851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Development of an experimental immunoglobulin test system based on anti-idiotypic immunoglobulins for the determination of specific plague antibodies in serum of patients inoculated with the live plague vaccine EV NIIEG].
    Fedorova VA; Devdariani ZL
    Klin Lab Diagn; 2006 Apr; (4):54-6. PubMed ID: 16756169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model.
    Shreewastav RK; Ali R; Uppada JB; Rao DN
    Cell Immunol; 2012; 278(1-2):55-62. PubMed ID: 23121976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective efficacy of a fully recombinant plague vaccine in the guinea pig.
    Jones SM; Griffin KF; Hodgson I; Williamson ED
    Vaccine; 2003 Sep; 21(25-26):3912-8. PubMed ID: 12922126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of bubonic and pneumonic plague using plant-derived vaccines.
    Alvarez ML; Cardineau GA
    Biotechnol Adv; 2010; 28(1):184-96. PubMed ID: 19931370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yersinia pestis (plague) vaccines.
    Titball RW; Williamson ED
    Expert Opin Biol Ther; 2004 Jun; 4(6):965-73. PubMed ID: 15174978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffkine and freeze-dried plague vaccine.
    Meyer KF; Smith G; Foster LE; Marshall JD; Cavanaugh DC
    J Infect Dis; 1974 May; 129():Suppl:S30-6. PubMed ID: 4825247
    [No Abstract]   [Full Text] [Related]  

  • 50. [The effect of a vaccinal strain of the plague microbe on C3-receptor expression on the surfaces of peritoneal and alveolar macrophages].
    Vasil'eva GI; Tkachenko LN; Doroshenko EP; Gamleshko KhP; Balatskaia TA
    Mikrobiol Z; 1994; 56(4):25-9. PubMed ID: 9181978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine.
    Bubeck SS; Dube PH
    Clin Vaccine Immunol; 2007 Sep; 14(9):1235-8. PubMed ID: 17652523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Biological activity of the components of F1-antigen of Yersinia pestis].
    Kosse LV; Lebedeva SA; Cherniavskaia AS; Nekliaev VN; Markina OV; Morozova IV; Eremenko NS; Sal'nikova OI
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):76-81. PubMed ID: 16830596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
    Honko AN; Sriranganathan N; Lees CJ; Mizel SB
    Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT; Eyles JE; Baillie LW; Keane-Myers AM
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):505-9. PubMed ID: 22515653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
    Uppada SB; Bhat AA; Sah A; Donthamshetty RN
    Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Influence of neutrophilokines on the synthesis of lymphokines in the process of the formation of immunity to plague].
    Vasil'eva GI; Kozlovskiĭ VN; Kiseleva AK; Bespalova IA; Ivanova IA; Mishan'kin MB; Doroshenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):61-5. PubMed ID: 15773403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunogenicity of B-antigen in experimental plague and pseudotuberculosis].
    Byvalov AA; Krupin VV; Gavrilov KE
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):49-53. PubMed ID: 16830590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice.
    Anisimov AP; Shaikhutdinova RZ; Pan'kina LN; Feodorova VA; Savostina EP; Bystrova OV; Lindner B; Mokrievich AN; Bakhteeva IV; Titareva GM; Dentovskaya SV; Kocharova NA; Senchenkova SN; Holst O; Devdariani ZL; Popov YA; Pier GB; Knirel YA
    J Med Microbiol; 2007 Apr; 56(Pt 4):443-453. PubMed ID: 17374882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis).
    Rocke TE; Iams KP; Dawe S; Smith SR; Williamson JL; Heisey DM; Osorio JE
    Vaccine; 2009 Dec; 28(2):338-44. PubMed ID: 19879228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A filtered non-toxic plague vaccine which protects guinea-pigs and mice.
    Smith H; Packman LP
    Br J Exp Pathol; 1966 Feb; 47(1):25-34. PubMed ID: 5908699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.